-
State Sen. Eva Burch hopes her experiences will convince her colleagues to leave abortion access up to doctors — and Arizona voters — this fall.
-
At issue is the FDA's regulatory power to approve drugs and continually evaluate their safety — a system that until now has been widely viewed as the gold standard for both safety and innovation
-
The case could affect not just abortion access but oversight of the drug industry and the authority of federal agencies. The court hears arguments Tuesday.
-
The report finds that the ban has caused delays and denial of medical care and forced doctors to navigate between ethical duties to patients and their fear of penalties and prosecution.
-
For years, Republicans pushed "life at conception." IVF is complicating that message as GOP lawmakers struggle to agree on a path forward.
-
A bill that would make it a felony for non-medical professionals to deliver abortion-inducing drugs passed the Oklahoma House floor on party lines with a vote of 77-18.
-
Vice President Harris toured a Minnesota abortion clinic during a trip to the Twin Cities on Thursday. It's believed to be a first for a vice president or president.
-
The majority of American voters, including Republicans, support protecting access to abortion for women who are experiencing pregnancy-related emergencies, such as miscarriages, a KFF poll finds.
-
Fetal personhood made headlines recently when the Alabama Supreme Court ruled that embryos are "extrauterine children." The ruling raised questions across the country about fetal personhood.
-
CVS will start filling prescriptions for mifepristone in Massachusetts and Rhode Island. Walgreens will start in New York, Pennsylvania, Massachusetts, California and Illinois.